[1] Chamani G, Rad M, Zarei MR, et al. Efficacy of tacrolimus and clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis [J]. Int J Dermatol, 2015, 54(9)∶996-1004 [2] 曹直. miR-155在口腔扁平苔藓患者外周血及组织中表达及意义[J].口腔医学研究, 2016, 32(2)∶185-188 [3] Simark-Mattsson C, Eklund C. Reduced immune responses to purified protein derivative and Candida albicans in oral lichen planus [J]. J Oral Pathol Med, 2013, 42(9)∶691-697 [4] Loyer X, Mallat Z, Boulanger CM, et al. MicroRNAs as therapeutic targets in atherosclerosis [J]. Expert Opin Ther Targets, 2015, 19(4)∶489-496 [5] Ji JD, Cha ES, Lee WJ. Association of miR-146a polymorphisms with systemic lupus erythematosus: a meta-analysis [J]. Lupus, 2014, 23(10)∶1023-1030 [6] Gao M, Wang X, Zhang X, et al. Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression [J]. J Immunol, 2015, 195(2)∶672-682 [7] Liu Z, Xiao B, Tang B, et al. Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells [J]. Microbes Infect, 2010, 12(11)∶854-863 [8] 中华口腔医学会口腔黏膜病专业委员会,中华口腔医学会中西医结合专业委员会,周红梅.口腔扁平苔藓诊疗指南(试行)[J].中华口腔医学杂志,2012,47(7)∶399-401 [9] Vered M, Fürth E, Shalev Y, et al. Inflammatory cells of immunosuppressive phenotypes in oral lichen planus have a proinflammatory pattern of expression and are associated with clinical parameters [J]. Clin Oral Investig, 2013, 17(5)∶1365-1373 [10] Ji JD, Cha ES, Lee WJ. Association of miR-146a polymorphisms with systemic lupus erythematosus: a meta-analysis [J]. Lupus, 2014, 23(10)∶1023-1030 [11] 王之遥,申乐,魏敏,等.miR-146a激动剂对大鼠神经病理性疼痛行为学和IRAKl、TRAF6表达的影响[J].中国疼痛医学杂志,2015,21(6)∶406-416 [12] 何孝亮,李向培,陶金辉,等.微小RNA-146a肿瘤坏死因子受体相关因子6白细胞介素-1受体相关激酶1在强直性脊柱炎患者外周血中的表达及其意义[J].中华风湿病学杂志,2013,17(2)∶119-123 [13] Park SM, Park SY, Kim JH, et al. Genome-wide mRNA profiling and multiplex quantitative RT-PCR for forensic body fluid identification [J]. Forensic Sci Int Genet, 2013, 7(1)∶143-150 [14] Raphael I, Webb J, Stuve O, et al. Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future [J]. Expert Rev Clin Immunol, 2015, 11(1)∶69-91 [15] Kaur J, Jacobs R. Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis [J]. J Korean Assoc Oral Maxillofac Surg, 2015, 41(4)∶171-175 [16] Yousefzadeh N, Alipour MR, Soufi FG. Deregulation of NF-кB-miR-146a negative feedback loop may be involved in the pathogenesis of diabetic neuropathy [J]. J Physiol Biochem, 2015, 71(1)∶51-58 |